JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Theo Kofidis
Axel Haverich
Uwe Klima
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sommer, S.-P.
Right arrow Articles by Klima, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sommer, S.-P.
Right arrow Articles by Klima, U.
Related Collections
Right arrow Valve disease

J Thorac Cardiovasc Surg 2005;130:212-213
© 2005 The American Association for Thoracic Surgery


Brief Communication

Ross procedure with a quadricuspid pulmonary autograft

Sebastian-Patrick Sommer, MD, Christoph Bara, MD, Theo Kofidis, MD, Axel Haverich, MD, PhD, Uwe Klima, MD, PhD *

Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Hannover, Germany.

Received for publication October 7, 2004; accepted for publication November 23, 2004.

* Address for reprints: Uwe Klima, MD, Division of Thoracic and Cardiovascular Surgery, Hannover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany (Email: klima@thg.mh-hannover.de).

The first 20% of the full text of this article appears below.

Aortic valve replacement using the pulmonary autograft as described by Ross1Go in 1967 is an excellent permanent therapy for aortic valve disease, particularly in young patients. This procedure facilitates the omission of anticoagulation. The pulmonary autograft displays a superior longevity and excellent hemodynamic properties in combination with a low incidence of thromboembolism compared with all other aortic valve replacement procedures. However, its success is dictated by the suitability of the pulmonary autograft before the switch to the aortic position; a normal pulmonary valve (PV) without anatomic abnormalities is a prerequisite for the achievement of a satisfying operative and hemodynamic result.

We report on the postoperative outcome and midterm follow-up (4 years) of a 48-year-old female patient who underwent . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The American Association for Thoracic Surgery.